One World Products, Inc. (OWPC) Stock Price & Analysis
One World Products, Inc. (OWPC) rose 0.00% to USD 0 as of September 8, 2026 at 14:48 UTC, according to Nexqual real-time market data.
OWPC last closed at USD 0; the session ranged USD 0–0 on volume of 20,000 shares. Market capitalization is —, with a 52-week range of USD 0–0.1 (PNK). Source: Nexqual, September 8, 2026 at 14:48 UTC.
Key Statistics (as of September 8, 2026 at 14:48 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.1 |
| Volume | 20,000 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (OWPC)
Nexqual's technical model rates OWPC "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:48 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.63 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
From One World Products, Inc.'s Latest SEC 10-K Filing (filed 2025-06-03)
Partnerships
- In October of 2024, the Company, in collaboration with partners in the automotive industry, developed hemp-based molded containers for automotive part packaging applications and received an initial order for 1,400 units of these reusable totes, designed to move and protect automotive parts through the supply chain.   Products   Our business currently involves the sale of CBD based product in the United States, called Pro-11.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBRRF | Blueberries Medical Co. | USD 0.01 | ▲ 12.88% |
| AVCNF | Avicanna Inc. | USD 0.1 | ▲ 11.76% |
| MMND | Mastermind, Inc. | USD 0 | ▲ 0% |
| ALID | Allied Corp. | USD 0 | ▲ 0% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:48 UTC. This page is informational and not investment advice.